Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 27 tags : Fda save search
FDA, NIH, and 15 private organizations join forces to increase effective gene therapies for rare diseases
Published: 2021-10-27 (Crawled : 20:00) - fda.gov
TMO | News | $573.21 -0.24% 940K
|
Health Technology
|
| O: 0.44%
H: 2.01%
C: 0.82%
TAK | News | $13.215 -1.23% 420K
|
Health Technology
|
| O: 2.03%
H: 3.33%
C: 0.07%
RGNX | $15.75 -0.94% 120K
|
Health Technology
|
| O: 0.91%
H: 2.93%
C: 2.79%
BIIB | $202.7 4.93% 1.6M
|
Health Technology
|
| O: 0.19%
H: 2.32%
C: 1.7%
disease fda gene therapies therapy gene therapy rare
Amneal Launches Generic Dexamethasone Following ANDA Approval by FDA
Published: 2021-10-27 (Crawled : 14:15) - biospace.com/
AMRX | $5.885 8.98% 1.3M
|
Health Technology
|
| O: -0.72%
H: 0.0%
C: -2.91%
fda approval
Ocugen, Inc. Announces Submission of Investigational New Drug Application with U.S. FDA to Initiate a Phase 3 Clinical Trial Evaluating COVID-19 Vaccine Candidate COVAXIN™ (BBV152)
Published: 2021-10-27 (Crawled : 11:00) - globenewswire.com
OCGN | News A | $1.185 -5.2% 4.2M
|
Health Technology
|
| O: 0.44%
H: 7.18%
C: 4.57%
covid new drug fda application vaccine drug phase 3 trial submission bbv152
Gainers vs Losers
| 55% | 45% |
Top 10 Gainers
CZOO | $10.52 110.82% 10M
|
CSSE 4 | $0.3181 108.86% 170M
|
Consumer Services
BOF | $1.88 60.68% 98M
|
AMST | $3.1 55.0% 66M
|
Technology Services
LICN | $0.8592 53.43% 13M
|
WIMI | $1.03 41.99% 15M
|
Technology Services
MULN | News | $3.675 34.62% 11M
|
Information
RILY | $28.605 31.7% 9.9M
|
Finance
RBBN 4 | $3.305 28.6% 1.9M
|
Electronic Technology
RCAT | $1.53 27.5% 2.9M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.